AT471150T - Methods used in plasma or serum extracted extracellurae rna for diagnosis monitoring or evaluation of cancer - Google Patents

Methods used in plasma or serum extracted extracellurae rna for diagnosis monitoring or evaluation of cancer

Info

Publication number
AT471150T
AT471150T AT97915870T AT97915870T AT471150T AT 471150 T AT471150 T AT 471150T AT 97915870 T AT97915870 T AT 97915870T AT 97915870 T AT97915870 T AT 97915870T AT 471150 T AT471150 T AT 471150T
Authority
AT
Austria
Prior art keywords
extracellurae
rna
cancer
plasma
evaluation
Prior art date
Application number
AT97915870T
Other languages
German (de)
Inventor
Michael Kopreski
Original Assignee
Kopreski Michael S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
Priority to US1473096P priority Critical
Application filed by Kopreski Michael S filed Critical Kopreski Michael S
Priority to PCT/US1997/003479 priority patent/WO1997035589A1/en
Publication of AT471150T publication Critical patent/AT471150T/en
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21767359&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AT471150(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/16Primer sets for multiplex assays
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/14Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333Saccharide [e.g., DNA, etc.]
AT97915870T 1996-03-26 1997-03-14 Methods used in plasma or serum extracted extracellurae rna for diagnosis monitoring or evaluation of cancer AT471150T (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US1473096P true 1996-03-26 1996-03-26
PCT/US1997/003479 WO1997035589A1 (en) 1996-03-26 1997-03-14 Method enabling use of extracellular rna extracted from plasma or serum to detect, monitor or evaluate cancer

Publications (1)

Publication Number Publication Date
AT471150T true AT471150T (en) 2010-07-15

Family

ID=21767359

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97915870T AT471150T (en) 1996-03-26 1997-03-14 Methods used in plasma or serum extracted extracellurae rna for diagnosis monitoring or evaluation of cancer

Country Status (9)

Country Link
US (8) US6329179B1 (en)
EP (1) EP0938320B2 (en)
AT (1) AT471150T (en)
CA (1) CA2250118C (en)
DE (1) DE69739909D1 (en)
DK (1) DK0938320T3 (en)
ES (1) ES2347854T5 (en)
PT (1) PT938320E (en)
WO (1) WO1997035589A1 (en)

Families Citing this family (177)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8048629B2 (en) 1996-03-15 2011-11-01 The Penn State Research Foundation Detection of extracellular tumor-associated nucleic acid in blood plasma or serum
US6156504A (en) * 1996-03-15 2000-12-05 The Penn State Research Foundation Detection of extracellular tumor-associated nucleic acid in blood plasma or serum using nucleic acid amplification assays
US6511805B1 (en) * 1996-03-15 2003-01-28 The Penn State Research Foundation Methods for detecting papillomavirus DNA in blood plasma and serum
US8163524B2 (en) * 1998-09-22 2012-04-24 Oncomedx, Inc. Comparative analysis of extracellular RNA species
US6607898B1 (en) * 1996-03-26 2003-08-19 Oncomedx, Inc. Method for detection of hTR and hTERT telomerase-associated RNA in plasma or serum
US8043835B1 (en) 1996-03-26 2011-10-25 Oncomedx, Inc. Methods for detecting and monitoring cancer using extracellular RNA
US6759217B2 (en) * 1996-03-26 2004-07-06 Oncomedx, Inc. Method enabling use of extracellular RNA extracted from plasma or serum to detect, monitor or evaluate cancer
US20070009934A1 (en) * 1997-03-14 2007-01-11 Kopreski Michael S Method enabling use of extracellular RNA extracted from plasma or serum to detect, monitor or evaluate cancer
US20090233276A1 (en) * 1998-09-22 2009-09-17 Oncomedx, Inc. Method Enabling the Use of Extracellular Ribonucleic Acid (RNA) Extracted from Plasma or Serum to Detect, Monitor or Evaluate Cancer or Premalignant Conditions
US20060204989A1 (en) * 1998-09-22 2006-09-14 Kopreski Michael S Comparative analysis of extracellular RNA species
AU8515701A (en) * 2000-08-28 2002-03-13 Oncomedx Inc Detection of 5t4 rna in plasma and serum
US7767422B2 (en) * 1998-09-22 2010-08-03 Oncomedx, Inc. Detection of 5T4 RNA in plasma and serum
US6794135B1 (en) 1996-03-26 2004-09-21 Oncomedx, Inc. Method for detection of 5T4 RNA in plasma or serum
US6329179B1 (en) 1996-03-26 2001-12-11 Oncomedx, Inc. Method enabling use of extracellular RNA extracted from plasma or serum to detect, monitor or evaluate cancer
US7785842B2 (en) 1996-03-26 2010-08-31 Oncomedx, Inc. Comparative analysis of extracellular RNA species
US8440396B2 (en) 1997-03-14 2013-05-14 Oncomedx, Inc. Method enabling use of extracellular RNA extracted from plasma or serum to detect, monitor or evaluate cancer
US6344317B2 (en) * 1996-10-04 2002-02-05 Chronix Biomedical, Inc. Diagnostic detection of nucleic acids
EP0972084A2 (en) 1997-04-11 2000-01-19 Micromet Gesellschaft für Biomedizinische Forschung mbH Primers and methods for the detection of disseminated tumor cells
WO1999047924A1 (en) * 1998-03-18 1999-09-23 Roche Diagnostics Gmbh Detection of apoptotic products
US7229772B1 (en) 1998-03-18 2007-06-12 Roche Diagnostics Gmbh Detection of apoptotic products
DE19836559A1 (en) * 1998-08-12 2000-03-23 Antigen Gmbh Blood collection vessel
EP1158055A1 (en) 2000-05-26 2001-11-28 Philippe Anker Method for diagnosing cancers
US6664056B2 (en) * 2000-10-17 2003-12-16 The Chinese University Of Hong Kong Non-invasive prenatal monitoring
WO2002079511A1 (en) * 2001-03-30 2002-10-10 Chronix Biomedical, Inc. Diagnostic detection of nucleic acids
AU2002345854A1 (en) * 2001-06-25 2003-01-08 Oncomedx, Inc. Methods for detecting and monitoring cox-2 rna in plasma and serum
AT502119T (en) * 2001-07-25 2011-04-15 Oncomedx Inc Method for evaluating pathological illicit states using extracellular rna
DE10143776A1 (en) * 2001-09-06 2003-04-03 Adnagen Ag Selection and determination of specific cells, useful particularly for diagnosis and monitoring of tumors, by antibody-mediated selection then detecting specific mRNA
DE10143775A1 (en) * 2001-09-06 2003-04-10 Adnagen Ag Selection and determination of specific cells, useful particularly for diagnosis and monitoring of tumors, by antibody-mediated selection then detecting specific mRNA
DE50204883D1 (en) 2001-09-06 2005-12-15 Adnagen Ag Process for the qualitative and / or quantitative detection of cells
US8986944B2 (en) 2001-10-11 2015-03-24 Aviva Biosciences Corporation Methods and compositions for separating rare cells from fluid samples
US8980568B2 (en) * 2001-10-11 2015-03-17 Aviva Biosciences Corporation Methods and compositions for detecting non-hematopoietic cells from a blood sample
CN1610752A (en) * 2001-10-26 2005-04-27 免疫公司 Multiparameter analysis of comprehensive nucleic acids and morphological features on the same sample
US20100159464A1 (en) * 2001-11-05 2010-06-24 Oncomedx, Inc. Method for Detection of DNA Methyltransferase RNA in Plasma and Serum
US20030104454A1 (en) * 2001-11-05 2003-06-05 Kopreski Michael S. Method for detection of DNA methyltransferase RNA in plasma and serum
WO2003044215A2 (en) * 2001-11-20 2003-05-30 Oncomedx, Inc. Methods for evaluating drug-resistance gene expression in the cancer patient
AU2002362055A1 (en) * 2001-12-03 2003-06-17 Oncomedx, Inc. Detection of matrix metalloproteinase rna in plasma and serum
EP2902501B1 (en) * 2002-01-28 2020-04-15 Life Technologies Corporation Preparing crude biological extracts using protease, suitable for preparing cDNA
US7727720B2 (en) * 2002-05-08 2010-06-01 Ravgen, Inc. Methods for detection of genetic disorders
US6977162B2 (en) 2002-03-01 2005-12-20 Ravgen, Inc. Rapid analysis of variations in a genome
WO2003076589A2 (en) * 2002-03-08 2003-09-18 Kopreski Michael S Analysis of apoptotic bodies in bodily fluids
US7022478B2 (en) * 2002-05-14 2006-04-04 The Chinese University Of Hong Kong Methods for evaluating stroke or cardiac ischemia by nucleic acid detection
US20040009518A1 (en) * 2002-05-14 2004-01-15 The Chinese University Of Hong Kong Methods for evaluating a disease condition by nucleic acid detection and fractionation
US7252976B2 (en) * 2002-08-28 2007-08-07 Board Of Regents The University Of Texas System Quantitative RT-PCR to AC133 to diagnose cancer and monitor angiogenic activity in a cell sample
US7074561B2 (en) * 2002-10-22 2006-07-11 Biomerieux, Inc. Isothermal amplification based assay for the detection and quantitation of alpha-fetoprotein mRNA
DE60323267D1 (en) * 2002-12-31 2008-10-09 Pfizer Prod Inc Rna-bioassay
US20040137539A1 (en) * 2003-01-10 2004-07-15 Bradford Sherry A. Cancer comprehensive method for identifying cancer protein patterns and determination of cancer treatment strategies
US20040178208A1 (en) * 2003-03-12 2004-09-16 Minh Leba Ice chest
JP4134047B2 (en) * 2003-03-19 2008-08-13 財団法人浜松科学技術研究振興会 Colorectal cancer marker detection method
TWI340168B (en) * 2003-05-07 2011-04-11 Tosoh Corp Method of detecting micrometastasis
EP1668111A4 (en) 2003-08-08 2008-07-02 Genenews Inc Osteoarthritis biomarkers and uses thereof
AT346170T (en) * 2003-10-29 2006-12-15 Maurice Stroun Method for the diagnosis of cancer
US20080261207A1 (en) * 2004-05-25 2008-10-23 Masato Mitsuhashi Method of Measuring Cancer Susceptibility
US20080268429A1 (en) * 2004-06-02 2008-10-30 Sourcepharm, Inc. Rna - Containing Microvesicles and Methods Therefor
US8021847B2 (en) 2004-06-02 2011-09-20 Proxy Life Science Holdings, Inc. Microvesicle-based compositions and methods
US20060003345A1 (en) * 2004-06-30 2006-01-05 Pfizer Inc RNA bioassay
EP1807537A2 (en) * 2004-10-07 2007-07-18 Chronix Biomedical, INC. Detection of nucleic acids to assess risk for creutzfeldt-jakob disease
US20090011410A1 (en) * 2004-10-20 2009-01-08 Masato Mitsuhashi Method for tailoring administration of drugs by quantitation of mrna
AT477497T (en) * 2004-12-08 2010-08-15 Cedars Sinai Medical Center Process for the diagnosis of morbus crohn
US7713695B2 (en) 2005-02-07 2010-05-11 Genenews, Inc. Mild osteoarthritis biomarkers and uses thereof
PL1712639T3 (en) 2005-04-06 2009-02-27 Maurice Stroun Method for the diagnosis of cancer by detecting circulating DNA and RNA
KR100983450B1 (en) * 2005-04-28 2010-09-20 히다치 가세고교 가부시끼가이샤 Ex vivo gene expression in whole blood as a model of assessment of individual variation to dietary supplements
CN101194027B (en) * 2005-06-08 2012-10-24 日立化成研究中心公司 Method for predicting immune response to neoplastic disease based on mRNA expression profile in neoplastic cells and stimulated leukocytes
US20090148840A1 (en) * 2005-08-10 2009-06-11 Hamamatsu Foundation For Science And Technology Promotion Method for detecting colon cancer markers
AT518007T (en) 2005-10-21 2011-08-15 Genenews Inc Method and device for correlating the levels of biomarker products with diseases
WO2007117589A2 (en) * 2006-04-07 2007-10-18 Hitachi Chemical Co., Ltd. Enhanced fc receptor-mediated tumor necrosis factor superfamily and chemokine mrna expression in peripheral blood leukocytes in patients with rheumatoid arthritis
WO2007117611A2 (en) * 2006-04-07 2007-10-18 Hitachi Chemical Co., Ltd. Enhanced t cell receptor-mediated tumor necrosis factor superfamily and chemokine mrna expression in peripheral blood leukocytes in patients with crohn's disease
US20070248961A1 (en) * 2006-04-20 2007-10-25 Maher Albitar Methods for detecting mutations in JAK2 nucleic acid
JP2009536524A (en) * 2006-05-08 2009-10-15 ヒタチ ケミカル リサーチ センター インコーポレイテッド Method for testing drug sensitivity of solid tumors by quantifying mRNA expression in sliced tumor tissue
US7798645B2 (en) * 2006-05-16 2010-09-21 Mark Costin Roser Visual and memory stimulating retina self-monitoring system
CN101583722A (en) 2006-07-14 2009-11-18 阿维瓦生物科学股份有限公司 Methods and compositions for detecting rare cells from a biological sample
WO2008101133A2 (en) * 2007-02-14 2008-08-21 Cedars-Sinai Medical Center Methods of using genes and genetic variants to predict or diagnose inflammatory bowel disease
WO2008106451A2 (en) * 2007-02-26 2008-09-04 Cedars-Sinai Medical Center Methods of using single nucleotide polymorphisms in the tl1a gene to predict or diagnose inflammatory bowel disease
US20100015156A1 (en) * 2007-03-06 2010-01-21 Cedars-Sinai Medical Center Diagnosis of inflammatory bowel disease in children
US8486640B2 (en) 2007-03-21 2013-07-16 Cedars-Sinai Medical Center Ileal pouch-anal anastomosis (IPAA) factors in the treatment of inflammatory bowel disease
WO2008118988A1 (en) 2007-03-26 2008-10-02 Sequenom, Inc. Restriction endonuclease enhanced polymorphic sequence detection
JP5926487B2 (en) 2007-04-13 2016-05-25 デイナ ファーバー キャンサー インスティチュート,インコーポレイテッド Method for treating cancer resistant to ErbB therapy
US20100184050A1 (en) * 2007-04-26 2010-07-22 Cedars-Sinai Medical Center Diagnosis and treatment of inflammatory bowel disease in the puerto rican population
WO2008137762A2 (en) * 2007-05-04 2008-11-13 Cedars-Sinai Medical Center Methods of diagnosis and treatment of crohn's disease
US7964350B1 (en) 2007-05-18 2011-06-21 Applied Biosystems, Llc Sample preparation for in situ nucleic acid analysis
US20090136942A1 (en) * 2007-09-18 2009-05-28 Oncomedx, Inc. Analysis of Extracellular RNA
US20090123920A1 (en) * 2007-11-08 2009-05-14 Maher Albitar Jak2 mutations
WO2009070442A2 (en) * 2007-11-14 2009-06-04 Hitachi Chemical Co. Ltd. Fc receptor-mediated tumor necrosis factor superfamily mrna expression in peripheral blood leukocytes
JP5676277B2 (en) * 2008-02-01 2015-02-25 ザ ジェネラル ホスピタル コーポレイション Use of microvesicles in the diagnosis, prognosis and treatment of medical diseases and conditions
US20090215064A1 (en) * 2008-02-27 2009-08-27 Hitachi Chemical Co., Ltd. Quantitative assessment of individual cancer susceptibility by measuring dna damage-induced mrna in whole blood
WO2009114543A2 (en) * 2008-03-11 2009-09-17 Sequenom, Inc. Nucleic acid-based tests for prenatal gender determination
WO2009120808A2 (en) 2008-03-26 2009-10-01 Sequenom, Inc. Restriction endonuclease enhanced polymorphic sequence detection
US8252529B2 (en) * 2008-06-12 2012-08-28 The Invention Science Fund I, Llc Methods for collecting and detecting oligonucleotides
US8614057B2 (en) * 2008-06-12 2013-12-24 The Invention Science Fund I, Llc Methods for collecting and detecting oligonucleotides
US8252528B2 (en) * 2008-06-12 2012-08-28 The Invention Science Fund I, Llc Methods, compositions, and kits for collecting and detecting oligonucleotides
CN102105598A (en) * 2008-06-20 2011-06-22 代理生命科学控股公司 Microvesicle-based compositions and methods
US8962247B2 (en) 2008-09-16 2015-02-24 Sequenom, Inc. Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non invasive prenatal diagnoses
US8476013B2 (en) 2008-09-16 2013-07-02 Sequenom, Inc. Processes and compositions for methylation-based acid enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses
US20110177969A1 (en) * 2008-10-01 2011-07-21 Cedars-Sinai Medical Center The role of il17rd and the il23-1l17 pathway in crohn's disease
US20110189685A1 (en) * 2008-10-22 2011-08-04 Cedars-Sinai Medical Center Methods of using jak3 genetic variants to diagnose and predict crohn's disease
CA2742324A1 (en) 2008-10-30 2010-06-03 Caris Life Sciences Luxembourg Holdings, S.A.R.L. Methods for assessing rna patterns
US9702877B2 (en) 2008-10-31 2017-07-11 Quest Diagnostics Investments Incorporated BCR-ABL variants
US7897356B2 (en) * 2008-11-12 2011-03-01 Caris Life Sciences Methods and systems of using exosomes for determining phenotypes
WO2010062960A2 (en) * 2008-11-26 2010-06-03 Cedars-Sinai Medical Center METHODS OF DETERMINING RESPONSIVENESS TO ANTI-TNFα THERAPY IN INFLAMMATORY BOWEL DISEASE
EP2955233A1 (en) * 2008-12-19 2015-12-16 Life Technologies Corporation Proteinase K inhibitors, methods and compositions therefor
WO2010075579A2 (en) 2008-12-24 2010-07-01 Cedars-Sinai Medical Center Methods of predicting medically refractive ulcerative colitis (mr-uc) requiring colectomy
US20100167271A1 (en) * 2008-12-30 2010-07-01 Streck, Inc. Method for screening blood using a preservative that may be in a substantially solid state form
WO2010079118A1 (en) 2009-01-07 2010-07-15 Michael Roth-Chiarello Use of rna obtained from proteolipid complexes circulating in blood for diagnosis and treatment of tumors
US20100184069A1 (en) * 2009-01-21 2010-07-22 Streck, Inc. Preservation of fetal nucleic acids in maternal plasma
US8304187B2 (en) * 2009-02-18 2012-11-06 Streck, Inc. Preservation of cell-free RNA in blood samples
US20110105585A1 (en) * 2009-04-23 2011-05-05 Northwestern University METHODS FOR DIAGNOSING AND TREATING SQUAMOUS CELL CARCINOMA UTILIZING miRNA-205 AND INHIBITORS THEREOF
EP2634266B1 (en) 2009-05-22 2015-10-14 Asuragen, INC. miRNA biomarkers of prostate disease
SG2014014617A (en) * 2009-07-16 2014-05-29 Gen Hospital Corp Nucleic acid analysis
JP5995721B2 (en) 2009-08-28 2016-09-21 アスラジェン, インコーポレイテッド MiRNA biomarkers for lung disease
WO2011031877A1 (en) 2009-09-09 2011-03-17 The General Hospital Corporation Use of microvesicles in analyzing nucleic acid profiles
US9488656B2 (en) * 2009-09-30 2016-11-08 Quest Diagnostics Investments Incorporated BCR-ABL truncation mutations
ES2571104T3 (en) * 2009-11-09 2016-05-24 Streck Inc Stabilization of RNA and extraction of RNA present in intact cells within a blood sample
WO2011087760A2 (en) 2009-12-22 2011-07-21 Sequenom, Inc. Processes and kits for identifying aneuploidy
CA2791905A1 (en) 2010-03-01 2011-09-09 Caris Life Sciences Luxembourg Holdings, S.A.R.L. Biomarkers for theranostics
US9469876B2 (en) 2010-04-06 2016-10-18 Caris Life Sciences Switzerland Holdings Gmbh Circulating biomarkers for metastatic prostate cancer
WO2011154940A1 (en) * 2010-06-07 2011-12-15 Osnat Ashur-Fabian Methods and kits for diagnosing conditions related to hypoxia
WO2011156734A2 (en) * 2010-06-11 2011-12-15 Hitachi Chemical Co., Ltd. Method of characterizing vascular diseases
JP5755326B2 (en) 2010-06-11 2015-07-29 日立化成株式会社 How to determine the characteristics of renal function
US20140342940A1 (en) 2011-01-25 2014-11-20 Ariosa Diagnostics, Inc. Detection of Target Nucleic Acids using Hybridization
US10167508B2 (en) 2010-08-06 2019-01-01 Ariosa Diagnostics, Inc. Detection of genetic abnormalities
US20120034603A1 (en) 2010-08-06 2012-02-09 Tandem Diagnostics, Inc. Ligation-based detection of genetic variants
US20130261003A1 (en) 2010-08-06 2013-10-03 Ariosa Diagnostics, In. Ligation-based detection of genetic variants
WO2012031008A2 (en) * 2010-08-31 2012-03-08 The General Hospital Corporation Cancer-related biological materials in microvesicles
US8603740B2 (en) 2010-12-29 2013-12-10 Quest Diagnostics Investments Incorporated BCR-ABL1 splice variants and uses thereof
US10131947B2 (en) 2011-01-25 2018-11-20 Ariosa Diagnostics, Inc. Noninvasive detection of fetal aneuploidy in egg donor pregnancies
US8700338B2 (en) 2011-01-25 2014-04-15 Ariosa Diagnosis, Inc. Risk calculation for evaluation of fetal aneuploidy
US8756020B2 (en) 2011-01-25 2014-06-17 Ariosa Diagnostics, Inc. Enhanced risk probabilities using biomolecule estimations
GB201105295D0 (en) * 2011-03-29 2011-05-11 Univ Liverpool Cancer detection
EP3378954A1 (en) 2011-04-29 2018-09-26 Sequenom, Inc. Quantification of a minority nucleic acid species
WO2012151391A2 (en) 2011-05-04 2012-11-08 Streck, Inc. Inactivated virus compositions and methods of preparing such compositions
JP5823031B2 (en) 2011-06-10 2015-11-25 日立化成株式会社 Vesicle capture device and method for using the same
US20130040375A1 (en) 2011-08-08 2013-02-14 Tandem Diagnotics, Inc. Assay systems for genetic analysis
GB201115095D0 (en) * 2011-09-01 2011-10-19 Singapore Volition Pte Ltd Method for detecting nucleosomes containing nucleotides
US8712697B2 (en) 2011-09-07 2014-04-29 Ariosa Diagnostics, Inc. Determination of copy number variations using binomial probability calculations
EP2761020B1 (en) 2011-09-26 2018-06-13 Qiagen GmbH Stabilisation and isolation of extracellular nucleic acids
CN103930546A (en) 2011-09-26 2014-07-16 凯杰有限公司 Rapid method for isolating extracellular nucleic acids
EP2761000B1 (en) 2011-09-26 2016-03-16 PreAnalytiX GmbH Stabilisation and isolation of extracellular nucleic acids
CN104755628B (en) 2012-09-25 2019-03-01 凯杰有限公司 The stabilisation of biological sample
WO2013064163A1 (en) 2011-11-01 2013-05-10 Academisch Medisch Centrum Methylation markers for colorectal cancer
PT2809810T (en) 2012-01-06 2020-02-14 Viomics Inc System and method of detecting rnas altered by cancer in peripheral blood
WO2013116780A1 (en) 2012-02-03 2013-08-08 California Institute Of Technology Signal encoding and decoding in multiplexed biochemical assays
WO2013131021A1 (en) 2012-03-02 2013-09-06 Sequenom Inc. Methods and processes for non-invasive assessment of genetic variations
US9920361B2 (en) 2012-05-21 2018-03-20 Sequenom, Inc. Methods and compositions for analyzing nucleic acid
US10289800B2 (en) 2012-05-21 2019-05-14 Ariosa Diagnostics, Inc. Processes for calculating phased fetal genomic sequences
SG11201408651TA (en) 2012-06-27 2015-01-29 Berg Llc Use of markers in the diagnosis and treatment of prostate cancer
EP2875156A4 (en) 2012-07-19 2016-02-24 Ariosa Diagnostics Inc Multiplexed sequential ligation-based detection of genetic variants
US20160040229A1 (en) 2013-08-16 2016-02-11 Guardant Health, Inc. Systems and methods to detect rare mutations and copy number variation
US20190316185A1 (en) 2012-09-04 2019-10-17 Guardant Health, Inc. Systems and methods to detect rare mutations and copy number variation
US10041127B2 (en) 2012-09-04 2018-08-07 Guardant Health, Inc. Systems and methods to detect rare mutations and copy number variation
US9994897B2 (en) 2013-03-08 2018-06-12 Ariosa Diagnostics, Inc. Non-invasive fetal sex determination
US10450595B2 (en) 2013-03-15 2019-10-22 Theranos Ip Company, Llc Nucleic acid amplification
EP3587592A1 (en) 2013-03-15 2020-01-01 Theranos IP Company, LLC Nucleic acid amplification
KR20150132481A (en) 2013-03-15 2015-11-25 테라노스, 인코포레이티드 Nucleic Acid Amplification
EP3447141B1 (en) 2013-03-18 2020-08-05 PreAnalytiX GmbH Stabilisation of biological samples
WO2014146780A1 (en) 2013-03-18 2014-09-25 Qiagen Gmbh Stabilization and isolation of extracellular nucleic acids
CA2908553A1 (en) 2013-03-27 2014-10-02 Cedars-Sinai Medical Center Mitigation and reversal of fibrosis and inflammation by inhibition of tl1a function and related signaling pathways
US9662649B2 (en) 2013-05-06 2017-05-30 Hitachi Chemical Company America, Ltd. Devices and methods for capturing target molecules
US10316083B2 (en) 2013-07-19 2019-06-11 Cedars-Sinai Medical Center Signature of TL1A (TNFSF15) signaling pathway
US10091984B2 (en) 2013-07-24 2018-10-09 Streck, Inc. Compositions and methods for stabilizing circulating tumor cells
EP3674422A2 (en) 2013-09-06 2020-07-01 Theranos IP Company, LLC Systems and methods for detecting infectious diseases
FR3010530B1 (en) * 2013-09-11 2015-10-09 Univ Rouen Method of diagnosing malignant hemopathies and kit therefor
EP3049539B1 (en) 2013-09-25 2018-09-05 Bio-Id Diagnostic Inc. Methods for detecting nucleic acid fragments
SG11201604923XA (en) 2013-12-28 2016-07-28 Guardant Health Inc Methods and systems for detecting genetic variants
TW201617368A (en) 2014-09-05 2016-05-16 史坦森特瑞斯公司 Novel anti-MFI2 antibodies and methods of use
US10266895B2 (en) 2014-11-05 2019-04-23 Hitachi Chemical Company Ltd. Exosomes and microvesicles in intestinal luminal fluids and stool and use of same for the assessment of inflammatory bowel disease
WO2016077537A1 (en) 2014-11-12 2016-05-19 Hitachi Chemical Co., Ltd. Method and device for diagnosing organ injury
AU2015346185A1 (en) * 2014-11-14 2017-05-04 Liquid Genomics, Inc. Use of circulating cell-free RNA for diagnosis and/or monitoring cancer
SG11201704660YA (en) 2014-12-08 2017-07-28 Berg Llc Use of markers including filamin a in the diagnosis and treatment of prostate cancer
CN107613969A (en) 2015-03-31 2018-01-19 希洛斯医药品股份有限公司 The method being layered to the patient using Retinoic Acid Receptor Alpha agonist treatment
CA2978858A1 (en) 2015-06-10 2016-12-15 Qiagen Gmbh Method for isolating extracellular nucleic acids using anion exchange particles
EP3359693A4 (en) 2015-10-09 2019-03-06 Accuragen Holdings Limited Methods and compositions for enrichment of amplification products
US9868994B2 (en) 2016-04-08 2018-01-16 Syros Pharmaceuticals, Inc. Methods of stratifying patients for treatment with retinoic acid receptor-α agonists
EP3472354A4 (en) 2016-06-17 2020-01-01 California Institute of Technology Nucleic acid reactions and related methods and compositions
JP2019531710A (en) 2016-08-15 2019-11-07 アキュラーゲン ホールディングス リミテッド Compositions and methods for detecting rare sequence variants
US9850523B1 (en) 2016-09-30 2017-12-26 Guardant Health, Inc. Methods for multi-resolution analysis of cell-free nucleic acids
WO2018146162A1 (en) 2017-02-07 2018-08-16 Academisch Medisch Centrum Molecular biomarker for prognosis of sepsis patients
WO2019045803A1 (en) * 2017-09-01 2019-03-07 Genemo Inc. Methods for rna sequencing
CN108949906A (en) * 2018-06-22 2018-12-07 中南大学 A kind of dsDNA-AgNCs fluorescence probe and its construction method and application for HER2 detection

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1473096A (en) 1921-06-10 1923-11-06 Lawrence Paper Mfg Company Machine for making cellular board
US4383555A (en) * 1976-04-20 1983-05-17 Plastiflex Company International Helically wound hose from co-extruded profile with reinforcing ribs interlocked at adjacent convolutions
US4350156A (en) * 1980-05-29 1982-09-21 Japan Foundation For Artificial Organs Method and apparatus for on-line filtration removal of macromolecules from a physiological fluid
EP0048901B1 (en) * 1980-09-25 1985-07-31 Terumo Corporation Plasma separator
EP0091539B2 (en) * 1982-03-31 1996-11-27 Ajinomoto Co., Inc. Gene coding for interleukin-2 polypeptide, recombinant DNA carrying said gene, cell lines possessing the recombinant DNA,and method for producing interleukin-2 using said cells
US4699877A (en) * 1982-11-04 1987-10-13 The Regents Of The University Of California Methods and compositions for detecting human tumors
JPH0516868B2 (en) * 1985-05-31 1993-03-05 Kurare Kk
US4683195B1 (en) 1986-01-30 1990-11-27 Cetus Corp
EP0246709A1 (en) * 1986-05-20 1987-11-25 Stichting Katholieke Universiteit Recombinant DNA and cDNA, mRNA, protein, antibodies, and a method of detecting tumor cells
US5274087A (en) * 1986-08-13 1993-12-28 Molecular Diagnostics, Inc. cDNA coding for carcinoembryonic antigen (CEA)
EP0272098A3 (en) * 1986-12-15 1990-06-06 City Of Hope National Medical Center Method for amplification and detection of rna sequences
US5019243A (en) 1987-04-03 1991-05-28 Mcewen James A Apparatus for collecting blood
DE3717212A1 (en) 1987-05-22 1988-12-08 Viktor Dr Dr Med Balazs METHOD FOR THE EXAMINATION OF A CELLULAR BIOLOGICAL LIQUID FOR CELLULAR ONCOGEN TRANScripts or THEIR FRAGMENTS
US5532220A (en) * 1987-08-31 1996-07-02 The Regents Of The University Of California Genetic mechanisms of tumor suppression
US5124246A (en) 1987-10-15 1992-06-23 Chiron Corporation Nucleic acid multimers and amplified nucleic acid hybridization assays using same
US5350671A (en) * 1987-11-18 1994-09-27 Chiron Corporation HCV immunoassays employing C domain antigens
CA1340807C (en) 1988-02-24 1999-11-02 Lawrence T. Malek Nucleic acid amplification process
US4874858A (en) 1988-03-28 1989-10-17 The B. F. Goodrich Company Triazine-containing multisilane coupling agents for coating glass fibers, for adhesives, and for protective coatings
US4999290A (en) 1988-03-31 1991-03-12 The Board Of Regents, The University Of Texas System Detection of genomic abnormalities with unique aberrant gene transcripts
US4874853A (en) * 1988-04-18 1989-10-17 City Of Hope Synthetic oligonucleotides useful in diagnosis of chronic myelogenous leukemia
US5085983A (en) * 1988-08-19 1992-02-04 City Of Hope Detection of human tumor progression and drug resistance
US5098890A (en) * 1988-11-07 1992-03-24 Temple University-Of The Commonwealth System Of Higher Education Antisence oligonucleotides to c-myb proto-oncogene and uses thereof
US5087617A (en) * 1989-02-15 1992-02-11 Board Of Regents, The University Of Texas System Methods and compositions for treatment of cancer using oligonucleotides
WO1990009456A1 (en) 1989-02-16 1990-08-23 Viktor Balazs Malignancy test (cancer test) using the polymerase chain reaction
WO1991015516A2 (en) 1990-04-06 1991-10-17 Genelabs Incorporated Hepatitis c virus epitopes
US5217889A (en) * 1990-10-19 1993-06-08 Roninson Igor B Methods and applications for efficient genetic suppressor elements
US5155018A (en) 1991-07-10 1992-10-13 Hahnemann University Process and kit for isolating and purifying RNA from biological sources
CA2120336C (en) * 1991-10-04 2007-04-24 Beverly S. Emanuel Detecting digeorge syndrome mutations
WO1993017127A1 (en) * 1992-02-20 1993-09-02 The State Of Oregon Acting By And Through The Oregon State Board Of Higher Education On Behalf Of Oregon State University Boomerand dna amplification
DE69332642T2 (en) * 1992-10-29 2003-10-02 Thomas Jefferson University Ph Methods for detecting micrometasas in prostate cancer
US5429923A (en) * 1992-12-11 1995-07-04 President And Fellows Of Harvard College Method for detecting hypertrophic cardiomyophathy associated mutations
US5300635A (en) * 1993-02-01 1994-04-05 University Of Iowa Research Foundation Quaternary amine surfactants and methods of using same in isolation of nucleic acids
US6051374A (en) * 1994-02-14 2000-04-18 Abbott Laboratories Non-A, non-B, non-C, non-D, non-E hepatitis reagents and methods for their use
US5660979A (en) * 1994-11-04 1997-08-26 Akzo Nobel N.V. Detection of human retrovirus infection
WO1996029430A1 (en) 1995-03-17 1996-09-26 John Wayne Cancer Institute Detection of melanoma or breast metastases with a multiple marker assay
FR2737500B1 (en) * 1995-08-03 1997-08-29 Bio Merieux Viral material and nucleotide fragments associated with multiple sclerosis, for diagnosis, prophylactics and therapeutics
US6156535A (en) 1995-08-04 2000-12-05 University Of Ottawa Mammalian IAP gene family, primers, probes, and detection methods
CA2157416A1 (en) * 1995-09-01 1997-03-02 Kalyx Biosciences Inc. Method for enhancing detection ability of nucleic acid assays employing nucleic acid sequence based amplification
US5994062A (en) 1995-10-02 1999-11-30 The United States Of America As Represented By The Department Of Health And Human Services Epithelial protein and DNA thereof for use in early cancer detection
US6156504A (en) 1996-03-15 2000-12-05 The Penn State Research Foundation Detection of extracellular tumor-associated nucleic acid in blood plasma or serum using nucleic acid amplification assays
US6759217B2 (en) * 1996-03-26 2004-07-06 Oncomedx, Inc. Method enabling use of extracellular RNA extracted from plasma or serum to detect, monitor or evaluate cancer
US6794135B1 (en) * 1996-03-26 2004-09-21 Oncomedx, Inc. Method for detection of 5T4 RNA in plasma or serum
US6607898B1 (en) * 1996-03-26 2003-08-19 Oncomedx, Inc. Method for detection of hTR and hTERT telomerase-associated RNA in plasma or serum
US7767422B2 (en) 1998-09-22 2010-08-03 Oncomedx, Inc. Detection of 5T4 RNA in plasma and serum
US6329179B1 (en) 1996-03-26 2001-12-11 Oncomedx, Inc. Method enabling use of extracellular RNA extracted from plasma or serum to detect, monitor or evaluate cancer
US6344317B2 (en) * 1996-10-04 2002-02-05 Chronix Biomedical, Inc. Diagnostic detection of nucleic acids
WO1999067397A1 (en) 1998-06-25 1999-12-29 The General Hospital Corporation De novo dna cytosine methyltransferase genes, polypeptides and uses thereof
JP2002372533A (en) * 2001-06-13 2002-12-26 Kiwamu Akagi Examination method of blood, examination chip, and examination device
AU2002345854A1 (en) 2001-06-25 2003-01-08 Oncomedx, Inc. Methods for detecting and monitoring cox-2 rna in plasma and serum
AT502119T (en) 2001-07-25 2011-04-15 Oncomedx Inc Method for evaluating pathological illicit states using extracellular rna
EP2518163B1 (en) 2006-10-10 2014-08-06 The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. Prostate cancer specific alterations in erg gene expression and detection methods based on those alterations

Also Published As

Publication number Publication date
US6329179B1 (en) 2001-12-11
ES2347854T3 (en) 2010-11-04
EP0938320B2 (en) 2014-06-18
US6939671B2 (en) 2005-09-06
US8809020B2 (en) 2014-08-19
CA2250118C (en) 2009-09-29
US7932061B2 (en) 2011-04-26
US20070026427A1 (en) 2007-02-01
US20060228732A1 (en) 2006-10-12
ES2347854T5 (en) 2014-07-24
DE69739909D1 (en) 2010-07-29
US7767423B2 (en) 2010-08-03
EP0938320B1 (en) 2010-06-16
US20050003440A1 (en) 2005-01-06
US6916634B2 (en) 2005-07-12
ES2347854T9 (en) 2011-02-25
AU2318697A (en) 1997-10-17
WO1997035589A1 (en) 1997-10-02
US20060166229A1 (en) 2006-07-27
US8030031B2 (en) 2011-10-04
US20020155469A1 (en) 2002-10-24
EP0938320A1 (en) 1999-09-01
EP0938320B9 (en) 2010-11-03
PT938320E (en) 2010-09-22
US7972817B2 (en) 2011-07-05
AU722476B2 (en) 2000-08-03
US20080057502A1 (en) 2008-03-06
DK0938320T3 (en) 2010-10-18
US20020106684A1 (en) 2002-08-08
CA2250118A1 (en) 1997-10-02
EP0938320A4 (en) 2006-09-06

Similar Documents

Publication Publication Date Title
DK0950229T3 (en) Method, system and arrangement for determining the authenticity of persons
DE68915202D1 (en) Methods for the propagation and detection of nucleic acid sequences.
DE69834754D1 (en) Sample Analysis System
DE69914319D1 (en) Signal processing for measuring physiological analytes
DE69525888T2 (en) Signal analysis method using histograms
DE69739304D1 (en) Methods and compositions for the determination of sequences of nucleic acid molecules
DE69601720T2 (en) Method and device for determining dna sequence and detecting mutations
DE69506872D1 (en) Data collection or measurement during removal
DE69921463D1 (en) Method for performing blood cell counting
DE69514521D1 (en) Method for increasing the detection sensitivity of nucleic acid hybrids (target / sample)
DE69529324T2 (en) Process for determining the position of samples according to the position and orientation of an anchor for counterfeit detection
DE69635744D1 (en) Modified nucleic acid probes
DE69727128D1 (en) Disposable test strips for determining blood components and method for producing the same
DE69825303D1 (en) Method for measuring tissue structure
DE69723860D1 (en) METHOD FOR DETERMINING IgE
DE69713386T2 (en) Method for dna sequencing based on detection of the pyrophosphate release
DE69534950D1 (en) Compositions for the detection of proteases in biological samples and method for their use
BR9607497A (en) Nucleic acid probes for the detection and identification of fungi
DE69701612T2 (en) Method and compositions for analyzing nucleic acid molecules by measuring techniques
DE69828908D1 (en) Fluorimetric system for the detection of nucleic acids
AU8579898A (en) Method for detecting interval changes in radiographs
DE69902996T2 (en) Miscellaneous detection techniques
DE69713915D1 (en) Method for measuring the softness of banknotes
DE69836888D1 (en) Procedure for fluorescence detection test
DK2216416T3 (en) Methods for detecting nucleic acid sequences in urine

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0938320

Country of ref document: EP